UNC forms Conte Center for multidisciplinary schizophrenia research

October 22, 2002

The Department of Psychiatry at The University of North Carolina at Chapel Hill has received a five-year grant of over $9.3 million to form a new Silvio O. Conte Center for the Neuroscience of Mental Disorders to study the onset of schizophrenia. The new center brings together a diverse group of experts from four universities to conduct comprehensive studies of brain development in the earliest stages of life through early adulthood, when the disease is typically diagnosed.

The UNC Conte Center is one of 20 centers in the United States and one of only two named this year. Conte Centers are funded by the National Institute of Mental Health and were created to honor former U.S. Representative Silvio O. Conte, a longtime advocate for scientific research on brain diseases who died in 1991.

Dr. Jeffrey Lieberman, the Thad & Alice Eure Distinguished Professor of Psychiatry, Pharmacology and Radiology at the UNC-Chapel Hill School of Medicine, is the principal investigator for the UNC Conte Center. Dr. Anthony LaMantia, associate professor of cell and molecular physiology, and Dr. John Gilmore, professor of psychiatry, are co-principal investigators. They have assembled a multidisciplinary team of scientists from UNC, Duke University, Harvard University and the University of Washington to conduct the Center's research. This team is comprised of experts in many scientific fields, including adult and child psychiatry, medical genetics, obstetrics and gynecology, neonatology, radiology, computer science and biostatistics.

"The essential and distinctive aspect of this Center is that it unites the intellectual resources of four great universities and the expertise of individuals from diverse scientific disciplines," said Dr. Lieberman. "Through our collective findings, we hope to explain how certain behavioral and neurobiological factors transform apparently normal individuals to persons with the symptoms of schizophrenia. This could lead to more effective treatment and, possibly, prevention of this debilitating disease."

Conte Centers typically involve multiple research projects investigating severe mental illness. The UNC Conte Center will conduct four interrelated studies using distinct research methods. Researchers will attempt to identify critical brain events that trigger the development of psychotic symptoms associated with schizophrenia.

One study will use ultrasound and magnetic resonance imaging (MRI) to examine prenatal and neonatal brain development in the children of women with schizophrenia, a technique being used for the first time in schizophrenia research. Children will be monitored from the second trimester of pregnancy through two weeks after birth. The brain development of these children will be assessed from birth until age two with standardized tests of motor and language development and memory and attention. Findings from this study may allow early identification of high-risk children, making it possible to provide early intervention and prevent or mitigate the risk of developing schizophrenia or other neurodevelopmental disorders.

In other UNC Conte studies, researchers will track the development of healthy brains from infancy to early adulthood and use state-of-the-art neuroimaging to examine brain function in high-risk adolescents and young adults.

The Center also aims to develop a model for genetic and cellular influences of the GABAergic interneurons, which regulate the neural pathways most closely associated with the development of schizophrenia. "The plain and simple reality is that we do not know how or by what mechanism the brain develops abnormally in individuals with schizophrenia. We hope to explain what neurobiological and behavioral mechanisms are disrupted before the disease is diagnosed," Lieberman said.

UNC Conte Center research will be conducted from September 2002 through July 2007. In addition to Lieberman, LaMantia and Gilmore, principal investigators for the studies are Drs. Aysenil Belger, Guido Gerig, Robert Hamer, Fred Jarskog, Patricia Maness and Diana Perkins from UNC and Drs. Gregory McCarthy, Cecil Charles, Barbara Hertzberg and Richard Keefe from Duke.

The Conte grant is the second largest research award granted to the Department of Psychiatry. The department ranks seventh among psychiatry programs that receive funding from the National Institutes of Health, receiving $18 million in 2001. Overall, the UNC School of Medicine ranks 14th.
Note to media: Dr. Jeffrey A. Lieberman can be reached at 919-966-8990 or jlieberman@med.unc.edu
UNC Department of Psychiatry contact: Crystal Hinson, 919-966-9115 or chinson@med.unc.edu

University of North Carolina Health Care

Related Schizophrenia Articles from Brightsurf:

Schizophrenia: When the thalamus misleads the ear
Scientists at the University of Geneva (UNIGE) and the Synapsy National Centre of Competence in Research (NCCR) have succeeded in linking the onset of auditory hallucinations - one of the most common symptoms of schizophrenia - with the abnormal development of certain substructures of a region deep in the brain called the thalamus.

Unlocking schizophrenia
New research, led by Prof. LIU Bing and Prof. JIANG Tianzi from the Institute of Automation of the Chinese Academy of Sciences and their collaborators have recently developed a novel imaging marker that may help in the personalized medicine of psychiatric disorders.

Researchers discover second type of schizophrenia
In a study of more than 300 patients from three continents, over one third had brains that looked similar to healthy people.

New clues into the genetic origins of schizophrenia
The first genetic analysis of schizophrenia in an ancestral African population, the South African Xhosa, appears in the Jan.

Dietary supplement may help with schizophrenia
A dietary supplement, sarcosine, may help with schizophrenia as part of a holistic approach complementing antipsychotic medication, according to a UCL researcher.

Schizophrenia: Adolescence is the game-changer
Schizophrenia may be related to the deletion syndrome. However, not everyone who has the syndrome necessarily develops psychotic symptoms.

Study suggests overdiagnosis of schizophrenia
In a small study of patients referred to the Johns Hopkins Early Psychosis Intervention Clinic (EPIC), Johns Hopkins Medicine researchers report that about half the people referred to the clinic with a schizophrenia diagnosis didn't actually have schizophrenia.

The ways of wisdom in schizophrenia
Researchers at UC San Diego School of Medicine report that persons with schizophrenia scored lower on a wisdom assessment than non-psychiatric comparison participants, but that there was considerable variability in levels of wisdom, and those with higher scores displayed fewer psychotic symptoms.

Recognizing the uniqueness of different individuals with schizophrenia
Individuals diagnosed with schizophrenia differ greatly from one another. Researchers from Radboud university medical center, along with colleagues from England and Norway, have demonstrated that very few identical brain differences are shared amongst different patients.

Resynchronizing neurons to erase schizophrenia
Today, a decisive step in understanding schizophrenia has been taken.

Read More: Schizophrenia News and Schizophrenia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.